## LVS: Las Vegas Sands Corp. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.91 indicates fundamental undervaluation. Quality metrics strong (ROE 66%). Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-2.1% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($63.81)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Assenagon Asset Management S.A. Has $8.58 Million Holdings in Las Vegas Sands Corp. $LVS**
- Source: MarketBeat | 20251221T080804 | Somewhat-Bullish | Relevance: 100%
- Assenagon Asset Management S.A. significantly increased its stake in Las Vegas Sands Corp. (LVS) by 1,233.9% in Q3, now holding 159,415 shares valued at $8.58 million. This increase ininstitutional investment comes despite recent large insider sales totaling over $333 million. Analysts maintain a "Moderate Buy" consensus with an average target price of $67.52, driven by positive sentiment around Macau momentum and Singapore growth.

**2. Assenagon Asset Management S.A. Purchases 259,400 Shares of MGM Resorts International $MGM**
- Source: MarketBeat | 20251221T084121 | Neutral | Relevance: 64%
- Assenagon Asset Management S.A. significantly increased its stake in MGM Resorts International by 279.2% in Q3, purchasing 259,400 additional shares. This brings their total holdings to 352,298 shares, valued at approximately $12.21 million. Insider transactions also show IAC Inc. buying over 1 million shares, while MGM itself missed Q3 EPS estimates, facing a mixed analyst sentiment with a consensus "Hold" rating.

**3. Red Rock Resorts, Inc. (NASDAQ:RRR) Receives Consensus Recommendation of "Moderate Buy" from Analysts**
- Source: MarketBeat | 20251221T070941 | Neutral | Relevance: 64%
- Red Rock Resorts, Inc. (NASDAQ:RRR) has received a consensus recommendation of "Moderate Buy" from fourteen analysts, with an average 12-month target price of $64.42. The company recently reported strong quarterly earnings, beating estimates with $0.68 EPS, authorized a $300 million share repurchase, and increased its quarterly dividend to $0.26 per share. Institutional trading activity shows significant shifts in holdings, with several large investors increasing their stakes in RRR.

**4. Monarch Casino appoints new independent director to board**
- Source: MSN | 20251220T020840 | Neutral | Relevance: 56%
- Monarch Casino & Resort, Inc. (NASDAQ: MCRI) has appointed Ms. Christina M. Brennan to its Board of Directors as an independent director. This appointment expands the board to eight members, seven of whom are independent. Ms. Brennan brings extensive experience from the gaming and hospitality industries.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Goldman Sachs | $80 | $64 | +25% |
| 2025-12-08 | UBS | $68 | $67 | +1% |
| 2025-12-01 | Argus Research | $80 | $65 | +23% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Goldman Sachs | up | Buy |
| 2025-12-08 | UBS | main | Neutral |
| 2025-12-01 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 7 ($68.68M) |
| Sells | 12 ($14.30M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 6.2% (-2.0%)
- Capital Research Glo: 5.0% (-30.9%)
- Blackrock Inc.: 4.0% (-0.1%)
- Price (T.Rowe) Assoc: 2.2% (-7.8%)
- State Street Corpora: 2.1% (-7.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.1% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $14M sold (12 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +17%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.91 indicates undervaluation relative to growth. Forward P/E 21.0x stretched relative to 9% growth. Quality metrics strong (ROE 66%). Analyst sentiment positive (3 raises, avg +17%). Insider buying signal ($68.7M), management confidence. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $45.9B |
| Beta | 0.97 |
| 52W Range | $30.18 - $70.45 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.91 |
| Forward P/E | 21.0 |
| Current P/E | 23.0 |
| YoY Growth | 9.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 1.4% to -0.8% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.8pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.34x) but short-term weakness (below SMA20). RSI neutral at 57. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.75% (CS: 37) | Neutral |
| RSI_14 | 57.3 | Neutral |
| MACD Histogram | -0.33 | Bearish |
| vs SMA20 | 0.998x | Below |
| vs SMA50 | 1.077x | Above |
| vs SMA200 | 1.341x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $66.91
- **Stop Loss:** $63.81 (4.6% risk)
- **Target:** $73.11 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 290
- **Position Value:** $19,403.90
- **Portfolio %:** 19.40%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-28 (Est: $0.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.62 | $0.78 | +25.4% |
| 2025Q2 | $0.53 | $0.79 | +48.9% |
| 2025Q1 | $0.57 | $0.59 | +3.8% |
| 2024Q4 | $0.58 | $0.54 | -6.3% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*